Medical Weight Loss

Unlock Your Path to a Healthier Life: Discover Our Tailored Medical Weight Loss Solutions

Frequently Asked Questions (FAQs)

Semaglutide: mimics a hormone found in your body called GLP-1. This peptide therapy stimulates insulin productions, sends signals to your brain telling you that you are full, and slows gastric emptying helping you feel fuller for longer.

Tirzepatide: the only dual glucose-dependent insulin tropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist.

  • It induces weight loss by mimicking two hormones that stimulate insulin secretion, slows stomach emptying after a meal to help you feel fuller longer, and also increases lipid metabolism (fat breakdown).
  • Both semaglutide and tirzepatide are once weekly subcutaneous injections. They can be given at home or administered in-clinic.
  • We will gradually increase your dosage each month based on how well you are tolerating the medication
  • The most common side effects with both medications are gastrointestinal: nausea, vomiting, diarrhea, and constipation which can worsen at higher dosages
  • Most individuals have mild to moderate GI side effects and can be controlled with anti-nausea medications, eating smaller and more frequent meals, or by increasing the dose at a slower rate

Uncommon, but possible side effects include acute kidney injury, diabetic retinopathy (eye disease), gallbladder disease, severe GI symptoms, hypersensitivity (allergic) reactions, low blood glucose, medullary thyroid carcinoma (in animal studies), and pancreatitis. 

  • Results will be different for each person. You can safely expect to lose 1-2 pounds per week. Other factors such as diet and exercise will affect weight.
  • In clinical trials, participants on tirzepatide lost an average of 15-20% in body weight compared to placebo over a 72-week period. 
  • In clinical trials, participants on semaglutide lost an average of 5-15% weight reduction over a 68-week period.
  • It is expected you will lose at least 5% of your body weight over a 12-week period
  • Obesity is a chronic medical condition, and most individuals require life-long therapy.
  • It is recommended that you continue a maintenance dose of the medication to maintain your weight loss.
  • Individuals can choose to taper down or off the medication after 3 months, but should implement lifestyle changes to avoid weight regain.

Possibly. You should check with your primary care provider or insurance company if you have type 2 diabetes and BMI >30 with health-related comorbidity (type 2 diabetes, sleep apnea, osteoarthritis, hypertension) as it may be covered. It is ultimately your responsibility to find out.

We use a compounding pharmacy to prepare a generic form of the weight loss medications. It has the same active ingredient as the brand name medication.

  • The ongoing cost depends on the medication and your maintenance dose.
  • Average monthly cost of tirzepatide is $500
  • Average monthly cost of semaglutide is $400
  • You may be eligible for discounts for purchasing a 3-month supply

Aside from weight loss, semaglutide has been shown to reduce major cardiovascular events and improve heart failure symptoms. Weight loss improves sense of well-being, improves exercise function, reduces the conversion of prediabetes to type 2 diabetes, reduces blood pressure, reduces osteoarthritis-related knee pain, and improves obesity-related liver disease.